Endometrial cancer
A cancer that starts in the lining of the womb, and usually happens after the menopause. The main sign is bleeding from the vagina after the menopause, between periods, or heavier than is normal for you. The most common treatment is surgery to remove the womb, sometimes with radiotherapy, chemotherapy or hormone medicine. Most cases are found early, before the cancer has spread, and these are usually cured.
Read more about endometrial cancerTrial-stage treatments and research studies you can joinOpen trials for referral
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Filters
- Tests relacorilant with other treatments for gynecological cancers
Tests relacorilant with other drugs in adults with ovarian or endometrial cancer.
Aalst, BelgiumAlso Brussels, Charleroi, Hasselt, LeuvenAge 18+ - Tests trastuzumab deruxtecan with immunotherapy for HER2-expressing endometrial cancer
Tests a HER2-targeted drug with immunotherapy as first treatment in adults with advanced endometrial cancer.
Anderlecht, BelgiumAlso Leuven, LiègeAge 18+ - Tests BNT323 or chemotherapy in people with recurring HER2-expressing uterine cancer
Compares BNT323 with chemotherapy in adults with recurring uterine cancer previously treated with immunotherapy.
Anderlecht, BelgiumAlso Charleroi, Edegem, Kortrijk, Leuven, Liège, NamurAge 18+ - Tests sacituzumab tirumotecan with pembrolizumab in endometrial cancer
Tests sacituzumab tirumotecan plus pembrolizumab in adults with advanced endometrial cancer.
Brussels, BelgiumAlso Charleroi, Leuven, LiègeAge 18+ - Looking for cancer markers in self-collected urine and vaginal samples for gynecological cancers
Studies markers in self-collected samples from adults with gynecological cancers or postmenopausal bleeding.
Edegem, BelgiumAge 18+ - Tests ADU-1805 alone and with pembrolizumab in advanced solid tumors
Tests ADU-1805, alone or with pembrolizumab, in adults with advanced cancers.
Charleroi, BelgiumAge 18+ - Compares Rina-S with standard chemotherapy in endometrial cancer
Tests Rina-S against standard chemotherapy in adults with recurrent endometrial cancer.
Brussels, BelgiumAlso Edegem, Gilly, Leuven, Namur, Sint-NiklaasAge 18+ - EIK1005 alone or with pembrolizumab for advanced solid tumors
Tests EIK1005, alone and with pembrolizumab, in adults with advanced solid tumors.
Brussels, BelgiumAge 18+ - Tests patritumab deruxtecan in adults with several advanced solid tumors
Tests patritumab deruxtecan in adults with advanced solid tumors, including melanoma and gastric cancer.
Brussels, BelgiumAlso Edegem, Ghent, Jette, LeuvenAge 18+ - Tests ifinatamab deruxtecan in several types of recurrent or spreading solid tumors
Tests ifinatamab deruxtecan in adults with solid tumors that returned or spread.
Charleroi, BelgiumAlso Leuven, LiègeAge 18+ - Tests AZD8205 alone or combined in advanced solid tumors
Tests a new drug, AZD8205, in adults with advanced solid tumors, alone or combined.
Anderlecht, BelgiumAlso LeuvenAge 18+ - Tests XmAb541 for safety in people with advanced solid tumors
Tests the new drug XmAb541 for safety and dosing in advanced ovarian and endometrial cancers.
Kortrijk, BelgiumAlso Leuven, LiègeAge 15+ - Testing radiotherapy with durvalumab after surgery for mismatch-repair deficient endometrial cancer
Compares radiotherapy with durvalumab against radiotherapy with or without chemotherapy in endometrial cancer.
Anderlecht, BelgiumAlso Charleroi, Edegem, Leuven, Liège, Mons, Namur, Sint-Niklaas, TurnhoutAge 18+ - Tests ubamatamab alone or with cemiplimab in recurrent ovarian and uterine cancers
Tests ubamatamab, alone or with cemiplimab, in adults with recurrent ovarian or uterine cancer.
Edegem, BelgiumAlso LeuvenAge 18+ - Tests REGN5668 with other drugs in women with ovarian or uterine cancer
Tests REGN5668, alone or with other drugs, in adult women with gynecologic cancers.
Leuven, BelgiumAge 18+ - Puxitatug samrotecan compared with chemotherapy in B7-H4-selected endometrial cancer
Tests puxitatug samrotecan against chemotherapy in adults with advanced endometrial cancer that progressed.
Anderlecht, BelgiumAlso Charleroi, Edegem, Leuven, Liège, NamurAge 18+ - Tests a new drug, alone and with pembrolizumab, in advanced solid tumors
Tests safety of PF-08046054/SGN-PDL1V in adults with advanced solid tumor cancers.
Anderlecht, BelgiumAge 18+ - Tests tersolisib alone and combined with other cancer drugs in advanced solid tumors
Tests tersolisib, alone or with other drugs, in adults with advanced solid tumors.
Anderlecht, BelgiumAlso LeuvenAge 18+ - Long-term belzutifan treatment for adults with solid tumors or von Hippel-Lindau disease tumors
Continues belzutifan for adults with solid tumors or von Hippel-Lindau-related tumors.
Leuven, BelgiumAge 18+ - Compares Rina-S with standard treatment in endometrial cancer that has returned or spread
Tests Rina-S against the doctor's chosen treatment in adults with advanced endometrial cancer.
Charleroi, BelgiumAlso Edegem, Hasselt, Leuven, Liège, Namur, Sint-NiklaasAge 18+
Trials that have ended are not listed here, because nobody can join them. Stopped and finished Endometrial cancer trials (research view)
Take part in research
14 official research programmes take people with this disease. In a biobank or a registry you give a blood or tissue sample, or your health data, for many research teams to use.
See the research programmesSearch the publications
The results open on the publications page in a new tab, so this page stays as it is.
Lists with this disease filtered
Where treatment stands
Most people are found at an early stage, when this cancer is usually cured; once it has spread far, it is rarely cured.
Approved: 7
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 27
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 2
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 4
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 87 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for endometrial (womb) cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. EU approvals newer than that data come from the European Commission’s Union Register, checked on 17 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Belgium, for you and your family.
Endometrial cancer organisations in Belgium
- Cancerinfo – Fondation contre le Cancer
Free Belgian cancer information line of the Foundation Against Cancer for patients, relatives and the public with questions about cancer.
- Kankerlijn – Kom op tegen Kanker
Free Flemish cancer line where (former) cancer patients and relatives can anonymously get a listening ear, expert advice or information.
- Esperanza
Belgian peer support group for women with or after gynaecological cancer, offering a listening ear from woman to woman.
- Gynca’s
Belgian patient organisation supporting women with gynaecological cancer, their relatives and care workers.
- Kom op tegen Kanker
Flemish cancer charity (ECL member) working to prevent, fight and ease cancer, supporting patients and relatives and advocating for better cancer policy.
General support in Belgium
- Centre de Prévention du Suicide
Francophone Belgian centre offering a free 24/7 suicide prevention listening line (0800 32 123) and support at every stage of suicidal crisis.
- Zelfmoordlijn 1813
Anonymous, free suicide prevention line for Dutch-speaking Belgium (phone 1813 and chat), run by the Flemish Expertise Centre for Suicide Prevention.
- Federale Ombudsdienst Rechten van de patiënt
Federal mediation service (FPS Public Health) handling complaints about patient rights in care outside hospitals, e.g. GPs, dentists, home nurses.
International organisations
Frontlight Community
Endometrial cancer community in Belgium
People living with endometrial cancer and those close to them share what they went through. Posts are not medical advice: ask your doctor about your own treatment.
You need a Frontlight account with a verified e-mail address to comment.
Offer tissue or data
There are three ways to help research move faster.
Approved treatments
7 medicines are approved for endometrial cancer in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.
Approvals not in this list yet
Found for endometrial cancer in the regulators' official registers; the list below does not show these approvals yet. We read these registers every day.
- Lenvimalenvatinib
ApprovedApproved in the EU by the European Commission (medicine first authorised in the EU on 28 May 2015).
Approved for:
European Commission decision ›Endometrial Carcinoma (EC) LENVIMA in combination with pembrolizumab is indicated for the treatment of adult patients with advanced or recurrent endometrial carcinoma (EC) who have disease progression on or following prior treatment with a platinum-containing therapy in any setting and are not candidates for curative …
Checked on 18 Nov 2026 in the official lists of the US (FDA), the EU (European Commission and EMA) and Switzerland (Swissmedic), which we read every day. The lists of Japan (PMDA, approvals since April 2004), France (ANSM, medicines approved in France only) and Taiwan (TFDA) were checked on 11 Nov 2026. For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 4 uncertain matches are left out. Other countries' own approvals were not checked.
“Miracle cure” fact checker
Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
About endometrial cancer
Sources: NHS, NCI PDQ, MedlinePlus, NCI SEER
A cancer that starts in the lining of the womb, and usually happens after the menopause. The main sign is bleeding from the vagina after the menopause, between periods, or heavier than is normal for you. The most common treatment is surgery to remove the womb, sometimes with radiotherapy, chemotherapy or hormone medicine. Most cases are found early, before the cancer has spread, and these are usually cured.
What is it?
The womb (uterus) is where a baby grows during pregnancy. Endometrial cancer starts in the womb's lining, the endometrium. It is the most common kind of womb cancer. The cause is not known, but too much of the hormone oestrogen raises the risk.
It is most common in people who have been through the menopause, but anyone with a womb can get it. Being overweight, some kinds of hormone replacement therapy (HRT), diabetes, never having given birth, a late menopause and the breast cancer medicine tamoxifen raise the risk. It is more likely if close family have had womb, bowel or ovarian cancer, or with an inherited condition called Lynch syndrome. A healthy weight, regular exercise and a balanced diet can lower your chances.
The first signs
The most common sign is bleeding from the vagina that is not normal for you.
- bleeding or spotting after the menopause;
- heavy periods that are unusual for you, or bleeding between periods;
- a change in the discharge from your vagina;
- pain in the lower back or between the hips (pelvis), or pain during sex;
- a lump or swelling in your tummy, or peeing or pooing more or less often than usual.
How doctors find out
Your family doctor asks about your symptoms and may examine your tummy and vagina; you can ask for a female doctor or nurse. If cancer is possible, they send you to a specialist. You may have a scan with a small device placed in the vagina, blood tests, a look inside the womb with a thin camera (hysteroscopy), and a biopsy, where cells are taken from the womb lining. The tests can feel uncomfortable but should not hurt.
Results usually take a few weeks. If it is cancer, more scans (CT, MRI or PET) and genetic tests show how far it has spread. A specialist nurse is your main contact during and after treatment.
Current treatment
Surgery to remove the womb is the main treatment, sometimes followed by radiotherapy or chemotherapy to lower the chance of the cancer coming back; hormone therapy, immunotherapy or targeted medicines are used when it has spread or come back.
Will it get worse?
How serious it is depends on how big the cancer is, whether it has spread, and your general health. Irregular bleeding usually makes people see a doctor early, so most cases are found before the cancer has spread; about two in three are still only in the womb when found. Cancer that has spread to other parts of the body is rarely cured.
Medicines: what helps, and what to watch for
Chemotherapy uses medicines to kill cancer cells. It can be given after surgery to lower the chance of the cancer coming back, together with radiotherapy, or to slow the cancer and ease symptoms if it has spread. Hormone therapy blocks the hormones some of these cancers need to grow; it can help when the cancer has spread or you are not well enough for surgery or radiotherapy. Immunotherapy, which helps your immune system find and kill cancer cells, and targeted medicines may be options for advanced cancer or cancer that comes back.
Good to know:
- Common side effects of chemotherapy are tiredness, feeling sick, a sore mouth, hair loss for a while, and numbness or tingling in the hands or feet;
- Radiotherapy can cause tiredness, diarrhoea (which should go within a few weeks of treatment ending), vaginal dryness or narrowing, and the menopause;
- You do not need to wait for your next check-up to raise a side effect that worries you.
Radiotherapy, for some people
Radiotherapy uses high-energy rays to kill cancer cells. It can come from a machine outside the body or from a source placed inside, near the cancer. It may be given after surgery to lower the chance of the cancer coming back, and it can be the main treatment if you cannot have surgery. It can also ease symptoms.
Surgery, for some people
Surgery is the most common treatment, especially for early cancer. The surgeon removes the womb and the neck of the womb (cervix) in an operation called a hysterectomy. Sometimes the ovaries and fallopian tubes, nearby lymph nodes or the upper part of the vagina are removed too. If the cancer has spread or come back, surgery may also remove nearby parts, such as the ovaries and tubes, the bladder or the rectum. Recovery can take a long time. Your team will talk with you about what treatment means for having children.
Is there a cure?
Yes, often. When the cancer is found early and is only in the womb, treatment usually cures it. When it has spread far, it is rarely cured, and treatment aims to control it. Clinical trials are testing new treatments, and joining one may be an option for some people.
Median survival
About 3 years with chemotherapy for stage III or IV
Measured in: Stage III or IV, with chemotherapy: the GOG-0209 trial (1,381 women)
The figures behind it
NCI PDQ (health professional): in the GOG-0209 trial (1,381 women), median overall survival was 37 months with carboplatin plus paclitaxel and 41 months with paclitaxel, doxorubicin and cisplatin; in advanced or recurrent cancer after earlier platinum treatment, it was 18.7 months with pembrolizumab plus lenvatinib vs 11.9 months with chemotherapy (KEYNOTE-775). Most cases are found early, and localized disease is usually cured.
Sources
Written in plain words by Frontlight from these pages:
- NHS: Womb (uterus) cancer – Overview
- NHS: Womb (uterus) cancer – Symptoms
- MedlinePlus: Uterine Cancer
- NCI PDQ: Endometrial Cancer Treatment (PDQ) – Health Professional Version
- NHS: Womb (uterus) cancer – Causes
- NHS: Womb (uterus) cancer – Tests and next steps
- NCI SEER: Cancer Stat Facts: Uterine Cancer
- NHS: Womb (uterus) cancer – Treatment
- NCI PDQ: Endometrial Cancer Treatment (PDQ) – Patient Version
- NHS: Chemotherapy – Side effects
- NHS: Radiotherapy – Side effects